Contrast Media Injector Systems Services Located at the VA San Diego Healthcare System

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a separate written solicitation will not be issued. This combined synopsis/solicitation is issued as a request for quote (RFQ) VA262-17-Q-2057-1.



Submit written offers in accordance with Addendum to 52.212-1, Instruction to Offerors of this solicitation. Oral offers will not be accepted. All firms or individuals responding must be registered with the System for Award Management (SAM) (https://www.sam.gov). This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-95. North American Industrial Classification Standard (NAICS) 811219, with a size standard of $20.5M apply to this procurement.



This is a total service-disabled veteran-owned small business (SDVOSB) set-aside.



Please see Addendum to 52.212-1, Instructions to Offers on page 26-27 for quote submittal instructions.



Please see pages 26- 27 of the combined synopsis/solicitation for evaluation criteria.



Please see attached documents for detailed description of requirements.



All questions or comments must be provided to the contract Specialist (CS), Hyacinthe Luna, at the email below in writing via email no later than (NLT) October 26, 2017. I highlighted/commented on all the dates. Let s talk tomorrow about setting revised dates for this solicitation.

Answers will be posted NLT October 27, 2017.

Telephone and other means of oral communication will not be permitted.



Quotes must be sent to Contract Specialist, Hyacinthe Luna, hyacinthe.luna@va.gov no later than Thursday, November 9, 2017 at 11:00AM PDT.





The contract will be Firm-Fixed-Price with the CLIN structure reflected in the Price/Cost schedule. The anticipated period of performance will be for a base year from November 15, 2017 to November 14, 2018, and four (4) one-year options, exercisable at the discretion of the Government.